| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/18/2005 | WO2004028458A3 Antisense modulation of microsomal prostaglandin e2 synthase expression |
| 08/18/2005 | WO2004011595A3 Vectors for transferring molecules of interest in target cells |
| 08/18/2005 | WO2003072601A8 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | WO2002099049A3 Tbc1d1s as modifiers of the p53 pathway and methods of use |
| 08/18/2005 | WO2001058923A9 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 08/18/2005 | US20050183172 inhibition of flowering; sports fields; animal feed |
| 08/18/2005 | US20050183170 In vivo assembly of transcription units |
| 08/18/2005 | US20050183169 Transcription regulatory gene and peptide |
| 08/18/2005 | US20050183168 Plants having decreased dormancy period and methods producing the plants |
| 08/18/2005 | US20050183167 Microspore-specific promoter and method for producing hybrid plants |
| 08/18/2005 | US20050183166 Gene controlling flowering time and method for controlling flowering time in plants using the gene |
| 08/18/2005 | US20050183165 Grapevine leafroll virus (type 2) proteins and their uses |
| 08/18/2005 | US20050183162 Recombinant crop plants containing nucleotide sequences coding pokeweed antiviral protein (PAP) and comprising enhanced disease resistance; fungicides |
| 08/18/2005 | US20050183161 AXMI-010, a delta-endotoxin gene and methods for its use |
| 08/18/2005 | US20050183159 Floral organ tissue-specific expression of isopentenyl transferase |
| 08/18/2005 | US20050183155 herbicide resistance, insect resistance, resistance for bacterial, fungal, or viral disease, male fertility, male sterility, enhanced nutritional quality, and industrial usage |
| 08/18/2005 | US20050183154 the plant has such traits as herbicide resistance, insect resistance, resistance for bacterial, fungal, or viral disease, male fertility, male sterility, enhanced nutritional quality, and industrial usage |
| 08/18/2005 | US20050183153 Soybean cultivar 0509251 |
| 08/18/2005 | US20050183152 Soybean cultivar 2386009 |
| 08/18/2005 | US20050183150 Method for regenerating and transforming St. Augustinegrass from embryogenic callus |
| 08/18/2005 | US20050183149 Mouse exhibiting characteristics of Rothmund-Thomson syndrome and preparation method thereof |
| 08/18/2005 | US20050183148 Lymphocyte surface receptor that binds caml and methods of use thereof |
| 08/18/2005 | US20050183146 Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule |
| 08/18/2005 | US20050183145 Production of ungulates, preferably bovines that produce human immunoglobulins |
| 08/18/2005 | US20050182250 Nucleotide sequences coding fluorescent reporter protlein and scaffolds for use as diagnostic and imaging tool in genetic analysis |
| 08/18/2005 | US20050182248 Adensosine triphosphatase for use as tool to identify modulators for prevention and treatment of obesity, high blood pressure and connective tissue disorders |
| 08/18/2005 | US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 08/18/2005 | US20050182017 Immunostimulatory nucleic acid molecules |
| 08/18/2005 | US20050182016 promoter, the basal transcription regulatory region, and the transcription factor binding sites which are located upstream of, and are operatively linked to, the CRMP-1 gene; transfected cells |
| 08/18/2005 | US20050182015 Antisense modulation of EIF2C1 expression |
| 08/18/2005 | US20050182013 mixing oligonucleotide and a polymer to form complex wherein zeta potential of complex is not positive, inserting oligonucleotide into mammalian blood vessel in vivo, increasing permeability of blood vessel, passing complex through vessel |
| 08/18/2005 | US20050182012 NF-kappaB oligonucleotide decoy molecules |
| 08/18/2005 | US20050182010 Use of a nucleotide construct stably integrated in the genome of the target cells of the virus, which is able to produce a single transcript or multiple transcripts capable of forming a double-stranded RNA which inhibits replication of the virus |
| 08/18/2005 | US20050182009 siNA molecule comprising a double-stranded structure that down-regulates expression of NF-Kappa B / REL-A , wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 08/18/2005 | US20050182008 chemically synthesized double stranded siNA; NOGO genes encode potent inhibitors of neurite outgrowth; treating various nervous system disorders such as brain or spinal cord injury, cerebrovascular disorders, Alzheimer's disease, dementia, and neurodegenerative disorders |
| 08/18/2005 | US20050182007 siNA molecule comprising a double-stranded structure that down-regulates expression of interleukin and interleukin receptor , wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 08/18/2005 | US20050182006 Cancer and proliferative diseases |
| 08/18/2005 | US20050182005 Anti-microRNA oligonucleotide molecules |
| 08/18/2005 | US20050182004 Modulation of DC-SIGN expression |
| 08/18/2005 | US20050182003 Drugs to be used in gene therapy for recessively transmitted genetic disease |
| 08/18/2005 | US20050181997 For preservation of hematopoietic progenitor cells; useful for isolating rare, primitive progenitor cells; nontoxic |
| 08/18/2005 | US20050181995 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof |
| 08/18/2005 | US20050181982 Crystal structures of anti-factor IX Fab fragments and methods of use for peptidomimetic design |
| 08/18/2005 | US20050181509 Identifying transformed microorganism via positive and negative selection tools; improving heterologous gene expression |
| 08/18/2005 | US20050181508 Apparatus which utilizes alternating magnetic fields and biopolymer coated magnetically sensitive particles to transform membrane bound biological materials |
| 08/18/2005 | US20050181507 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 08/18/2005 | US20050181506 Chromosome-based platforms |
| 08/18/2005 | US20050181501 Anti-TECK antibodies and methods of use therefor |
| 08/18/2005 | US20050181500 A recombinant expression vector; an isolated nucleic acid molecule; diagnosis of high blood pressure, obesity |
| 08/18/2005 | US20050181494 Novel lambda phage display system and the process |
| 08/18/2005 | US20050181493 Mutant alpha-amylases |
| 08/18/2005 | US20050181490 Fermentation process for preparing coenzyme Q10 by the recombinant Agrobacterium tumefaciens |
| 08/18/2005 | US20050181489 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity |
| 08/18/2005 | US20050181488 Method for producing L-threonine using bacteria belonging to the genus Escherichia |
| 08/18/2005 | US20050181484 Culturing porcine bone marrow stem cells in nutrient broth comprising interleukins and colony stimulating factor; propagating mast cell |
| 08/18/2005 | US20050181483 Method for producing monoclonal antibodies |
| 08/18/2005 | US20050181482 Immunoglobulin/erythropoietin fusion for use in stimulating blood cell production |
| 08/18/2005 | US20050181480 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells |
| 08/18/2005 | US20050181479 Expression vector comprising nucleotide sequences coding single sequence, multimeric immunoglobulin |
| 08/18/2005 | US20050181476 Novel splice variant of MyD88 and uses thereof |
| 08/18/2005 | US20050181473 Bacterial adpglucose pyrophospatase method for obtaining the latter and its use in the production of assay devices and in the obtention of transgenic plants and bacteria |
| 08/18/2005 | US20050181472 proteins from Pseudomonas, having butynol I esterase activity; nucleotides sequences codes; expression cassettes, vectors and genetic engineered microorganisms; used for stereospecific hydrolysis or transesterification of organic esters |
| 08/18/2005 | US20050181462 Mutant androgen receptor, cancer cells expressing the same, a method of producing them and use thereof |
| 08/18/2005 | US20050181457 Mixture comprising immunogllobulin G complex for diagnosis, prevention and treatment of autoimmune and allergic disorders |
| 08/18/2005 | US20050181450 Novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein and an IP3 indicator |
| 08/18/2005 | US20050181448 Biological products |
| 08/18/2005 | US20050181446 Protein variants having modified immunogenicity |
| 08/18/2005 | US20050181441 Preparing solid support comprising immobilized nucleotide sequences for use in detection of preferential genic targets |
| 08/18/2005 | US20050181439 Streptococcus pneumoniae antigens and vaccines |
| 08/18/2005 | US20050181438 Nucleotide sequences coding monocarboxylate (MCT) transport protein for identifying modulators to treat hyperlysinemia; rational drug design and screening |
| 08/18/2005 | US20050181435 Mixture comprising thermostable structure-specific flap structure-specific endonuclease-1 (FEN-1) for use in cancer diagnosis and microorganismal detection |
| 08/18/2005 | US20050181434 Glucuronyl C5-epimerase, DNA encoding the same and uses thereof |
| 08/18/2005 | US20050181428 Expression vector comprising a ubiquitous chromatin opening element; CpG-island and tissue specific promoters for use in reproducible expression of heterologous gene sequences |
| 08/18/2005 | US20050181423 Automated methods of detecting receptor activity |
| 08/18/2005 | US20050181422 Process for high throughput screening of CpG-based immuno-agonist/antagonist |
| 08/18/2005 | US20050181419 For detection of Mycobacterium tuberculosis infection |
| 08/18/2005 | US20050181418 Using nuclear protein (AM-1) as screening tool in diagnosing metastatic cancer |
| 08/18/2005 | US20050181417 Using cell-free subcloning system comprising donor/acceptor vectors and site specific integration to replicate preferential nucleotide sequences |
| 08/18/2005 | US20050181414 Peptides associated with serine protease active site for use in identification of modulators for treatment of cell proliferative disorders |
| 08/18/2005 | US20050181413 Ovarian specific nucleic acid (OSNA) for use as diagnostic and prognostic tools in treatment and prevention of urogenital cancers; genetic vaccines |
| 08/18/2005 | US20050181412 Presenting list of genotypes at plurality of gene loci in plurality of individuals on basis of individual and gene locus data; bioinformatics |
| 08/18/2005 | US20050181407 Method for noncovalently immobilizing a biomolecule on a solid substrate and microarray produced according to the method |
| 08/18/2005 | US20050181406 HNF-1alpha gene including novel single-nucleotide polymorphism, protein encoded by the HNF-1alpha gene, and polynucleotide, microarray, kit, and method for diagnosis of MODY3 |
| 08/18/2005 | US20050181402 Immunoglobulin which specifically binds serum and glucocorticoid dependent kinase for diagnosing infection, inflammatory, kidney and liver disorders |
| 08/18/2005 | US20050181401 Reagents and methods useful for detecting diseases of the prostate |
| 08/18/2005 | US20050181400 Modulation of eIF4E-BP1 expression |
| 08/18/2005 | US20050181397 Nucleotide sequences coding sodium/bile co-transport protein for use in diagnosis, prevention and treatment of cell proliferative; pharmacogenomics |
| 08/18/2005 | US20050181395 Systems for tightly regulated gene expression |
| 08/18/2005 | US20050181391 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 08/18/2005 | US20050181385 Synthetic lethal screen using RNA interference |
| 08/18/2005 | US20050181383 Isolating, positioning, and sequencing single molecules |
| 08/18/2005 | US20050181382 Mediates silencing of a target gene; lessening the base pair strength between the 5' end of the first strand and the 3' end of a second strand of the duplex as compared to the base pair strength |
| 08/18/2005 | US20050181379 Method and device for isolating and positioning single nucleic acid molecules |
| 08/18/2005 | US20050181376 Antisense modulation of microsomal triglyceride transfer protein expression |
| 08/18/2005 | US20050181368 Protein for use in hypoxia related conditions |
| 08/18/2005 | US20050181367 Method of concentrating macromolecules or agglomerates of molecules or particles |
| 08/18/2005 | US20050181366 Molecular switches and methods for making and using the same |
| 08/18/2005 | US20050181365 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/18/2005 | US20050181363 Method of effecting lysis of acid-fast bacteria and method of performing gene amplification or detection therewith |